Search

Author/Creator Ferrante, Marc

45. Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. Issue 3 (1st April 2018)

Authors:
De Vos, Martine; Dhooghe, Barbara; Vermeire, Severine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis
Journal:
United European Gastroenterology journal
Issue:
Volume 6:Issue 3(2018)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

46. Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. Issue 3 (April 2018)

Authors:
De Vos, Martine; Dhooghe, Barbara; Vermeire, Severine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis
Journal:
United European Gastroenterology journal
Issue:
Volume 6:Issue 3(2018)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

47. Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. Issue 1 (January 2021)

Authors:
Stefanovic, Sebastian; Detrez, Iris; Compernolle, Griet; Brouwers, Els; Sever, Nejc; Stabuc, Borut; Smrekar, Natasa; Kurent, Tina; Novak, Gregor; Kozelj, Matic; Ferrante, Marc; Gils, Ann; Drobne, David
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 33:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

48. Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?. Issue 12 (3rd February 2017)

Authors:
Noben, Manuel; Verstockt, Bram; de Bruyn, Magali; Hendriks, Nikolai; Van Assche, Gert; Vermeire, Séverine; Verfaillie, Catherine; Ferrante, Marc
Journal:
Gut
Issue:
Volume 66:Issue 12(2017)
Page Start:
2193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

49. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. (25th August 2022)

Authors:
Torres, Joana; Chaparro, María; Julsgaard, Mette; Katsanos, Konstantinos; Zelinkova, Zuzana; Agrawal, Manasi; Ardizzone, Sandro; Campmans-Kuijpers, Marjo; Dragoni, Gabriele; Ferrante, Marc; Fiorino, Gionata; Flanagan, Emma; Gomes, Catarina Frias; Hart, Ailsa; Hedin, Charlotte Rose; Juillerat, Pas...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17:Number 1(2023)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

50. Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. Issue 1 (24th October 2019)

Authors:
Bronswijk, Michiel; Moens, Annick; Lenfant, Matthias; Tops, Sophie; Compernolle, Griet; Van Assche, Gert; Vermeire, Séverine; Gils, Ann; Ferrante, Marc
Journal:
Inflammatory bowel diseases
Issue:
Volume 26:Issue 1(2020)
Page Start:
161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗